Riskpilot← Back to searchSign inGet full accessCephalus Care AB
ABActiveOrg 5569196461Vipstigen 12General medical practice activities · NACE 8621Est. 20132 employees
Revenue 2025
SEK 7,3M
-5% vs 2024
EBITDA margin
54.1%
-16% vs 2024
Equity ratio
36.8%
Financial strength
Net profit 2025
SEK 4,5M
+221% vs 2024
| Revenue | SEK 7,3M | -5% |
| EBITDA | SEK 3,9M | -16% |
| Net profit | SEK 4,5M | +221% |
| Total assets | SEK 12,2M | +109% |
| Equity | SEK 4,5M | +8902% |
| Employees | 2 | — |
Legal name
Cephalus Care AB
Org number
5569196461
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
18 januari 2013
Share capital
SEK 50 000
Employees
2 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-08-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget skall bedriva läkarpraktik, musikverksamhet samt förvalta värdepapper och fast egendom samt därmed förenlig verksamhet.
Address
Vipstigen 12
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 7 370 | 7 165 | 7 194 | 7 681 | 7 297 |
| Staff expenses | — | — | — | — | — |
| EBITDA | 4 834 | 4 737 | 5 598 | 4 678 | 3 945 |
| Depreciation & amort. | −320 | −526 | −478 | −257 | −447 |
| EBIT | 4 514 | 4 211 | 5 120 | 4 421 | 3 498 |
| Net financials | −7 | −27 | 235 | −12 491 | 2 972 |
| Profit before tax | 2 841 | 3 198 | 3 810 | −2 973 | 4 869 |
| Tax | −613 | −669 | −704 | −710 | −418 |
| Net profit | 2 228 | 2 529 | 3 106 | −3 683 | 4 451 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 7 096 | 9 043 | 9 867 | 5 846 | 12 217 |
| Equity | 2 281 | 2 582 | 3 160 | 50 | 4 501 |
| Long-term debt | 723 | 623 | 0 | 0 | 412 |
| Short-term debt | 325 | 1 560 | 1 570 | 343 | 819 |
| Total debt | 1 048 | 2 183 | 1 570 | 343 | 1 231 |
EBITDA margin
54.1%
This company
15.8%
Market median
+242% vs market
20212025
Equity ratio
36.8%
This company
38.2%
Market median
+4% vs market
20212025
Return on equity
98.9%
This company
18.4%
Market median
+438% vs market
20212025
Net profit margin
61.0%
This company
8.1%
Market median
+653% vs market
20212025
Asset turnover
0.60×
This company
1.12×
Market median
-46% vs market
20212025
Debt / equity
1.71×
This company
0.62×
Market median
-176% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-09-01 – 2025-08-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-09-01 – 2024-08-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-09-01 – 2023-08-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-09-01 – 2022-08-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-09-01 – 2021-08-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
RM | Audit | 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2022 | |
| Deputy Board Member | 2025 | |
| Former (2) | ||
| Deputy Board Member | 2025 – 2025 | |
| Deputy Board Member | 2022 – 2025 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 0001 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Cephalus AB
Cephalus Care AB Board members of Cephalus Care AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Rickard Mats Yngve Julin | Audit | 0 companies |
| Sven Johan Nyberg | Board of Directors | 0 companies |
| Fabiola Nyberg | Deputy Board Member | 0 companies |
| Helena Susanna Nyberg | Deputy Board Member | 0 companies |
| Rosi Marie Katarina Nyberg | Deputy Board Member | 0 companies |